• J M Chen, H R Levin, K A Catanese, J J Sistino, D W Landry, E A Rose, and M C Oz.
• Department of Surgery, Columbia University College of Physicians & Surgeons, New York, N.Y., USA.
• J. Heart Lung Transplant. 1995 Jan 1; 14 (1 Pt 1): 186-91.

BackgroundDespite advances in the perioperative treatment of both heart transplant and left ventricular assist device recipients, right-sided circulatory failure refractory to medical management remains a major source of morbidity in the immediate postoperative period. In addition, hypervolemia is a frequent complication encountered in the treatment of these patients because of their large fluid intake requirements and relative potential for kidney failure.MethodsPrevious reports have documented the use of continuous-flow devices to support the failing right-sided circulation of patients after both left ventricular assist device insertion and orthotopic heart transplantation. However, such continuous-flow devices may carry the attendant risks of hemolysis and bleeding and may further require 24-hour monitoring by trained personnel. We report the temporary-use pulsatile Abiomed BVS 5000 right ventricular assist device and continuous arteriovenous hemodialysis in the recipient of a pulsatile TCI HeartMate 1000 IP left ventricular assist device both after left ventricular assist device implantation and after orthotopic heart transplantation.ResultsThe patient was well at 13 months follow-up.ConclusionsThe use of right ventricular assist devices and continuous arteriovenous hemodialysis in both transplant and left ventricular assist device recipients undoubtedly will remain important as the popularity of these two therapeutic modalities continues to grow.

17 keywords...

hide…